New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 2, 2011
06:54 EDTTLCRGrifols, Talecris Biotherapeutics sign consent agreement with FTC staff
Grifols, S.A. and Talecris Biotherapeutics Holdings announced they have signed a Consent Agreement with the staff of the Bureau of Competition of the U.S. Federal Trade Commission, or FTC, that outlines the conditions necessary for Grifols' acquisition of Talecris to proceed. The Consent Agreement remains subject to approval by the FTC Commissioners before the transaction can be completed. To satisfy the Consent Agreement conditions, Grifols has signed documents agreeing to the sale of select assets and has entered into certain commercial, lease and manufacturing agreements with the Italian company Kedrion for up to seven years. According to Grifols, neither the Consent Agreement nor the agreements signed with Kedrion will affect the operating synergies that Grifols expects to achieve through the acquisition of Talecris. Until the conclusion of the acquisition is formally announced, both companies remain independent and will conduct business as usual.
News For TLCR From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for TLCR

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use